Newsbreak

Oklahoma Supreme Court upholds abortion drug restriction

medication abortion, pill, abortion pill reversal

On Tuesday, the Oklahoma Supreme Court ruled in favor of upholding House Bill 2684, which restricts the use of abortion-inducing drugs. The legislation requires that doctors administer abortion-inducing drugs only while following Food and Drug Administration protocols.

The bill was signed in 2014 by Governor Mary Fallin, but last year, an abortion chain sued, claiming the FDA’s rules are outdated, and an Oklahoma judge overturned the bill, claiming it was unconstitutional. The state’s highest court disagreed, finding that House Bill 2684 does not violate constitutional provisions. However, the court also strangely took a dig at abortion safety laws, saying, “We also must recognize that, by the States’ own evidentiary materials, more restrictions on abortions result in higher complication rates and in decreased women’s safety.”

Pro-abortion groups, including the Oklahoma Coalition for Reproductive Justice, argued that the bill put unnecessary restrictions on women seeking an abortion. But the state’s high court held that the legislation simply makes healthcare laws uniform across the state.

As Live Action News reported, the Oklahoma House of Representatives is currently considering a bill that would require public high schools in the state to teach that human life begins at conception and would also “provide[] for the distribution of abortion prevention information and assistance, such as pregnancy help information.”

What is Live Action News?

Live Action News is pro-life news and commentary from a pro-life perspective. Learn More

Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.

GUEST ARTICLES: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated. (See here for Open License Agreement.) Thank you for your interest in Live Action News!



To Top